共 50 条
- [26] Subcutaneous anifrolumab for SLE: a new step forward? LANCET RHEUMATOLOGY, 2021, 3 (02): : E84 - E85
- [27] BLYS-targeted antibody shows promise in Phase III SLE trial Nature Reviews Drug Discovery, 2009, 8 : 688 - 688
- [29] Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial LUPUS SCIENCE & MEDICINE, 2023, 10 (02):